BGC 200166Alternative Names: BGC20-0166; COL-132
Latest Information Update: 20 Mar 2014
At a glance
- Originator BTG
- Mechanism of Action Serotonin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Sleep apnoea syndrome